Position
CSS LLC/IL in Pacira BioSciences, Inc.
Back to the book · All holders of PCRX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$2.99K$1.01 → $0.97
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 75K | $75.8K | — | — | — | 0.0% |
| Q1 2026 | 75K | $72.8K | $0.97 | −$2.99K | $0 | 0.0% |